Herpes zoster and postherpetic neuralgia. Optimal treatment

Drugs and Aging

Volumn 10, Issue 2, 1997, Pages 80-94

  Johnson, Robert W ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIVIRUS AGENT; CORTICOSTEROID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

AGED; HEALTH CARE COST; HEALTH ECONOMICS; HERPES ZOSTER; HUMAN; IMMUNITY; PATHOPHYSIOLOGY; POSTHERPETIC NEURALGIA; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SOCIAL PSYCHOLOGY; SYMPATHETIC BLOCKING; VACCINATION; VIRUS REPLICATION;

EID: 0031041111     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199710020-00002     Document Type: Review

References (111)

1. Ragozzino MW, Melton III LJ, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982; 61: 310-6
2. McGregor RM. Herpes zoster, chicken-pox and cancer in general practice. BMJ 1457; 1: 84-7
3. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965; 58: 9-20
4. Weksler ME. Immune senescence. Ann Neurol 1994; 35: 35-7
5. de Moragas M, Kierland RR. The outcome of patients with herpes zoster. AMA Arch Dermatol 1957; 75: 193-6
6. Hope-Simpson RE. Postherpetic neuralgia. J R Coll Gen Pract 1975; 25: 571-5
7. Dworkin RH, Portenoy RK. Proposed classification of herpes zoster pain [letter]. Lancet 1994; 343: 1648
8. Wood MJ, Group HZCTC. How should zoster trials be conducted? J Antimicrob Chemother 1995; 36: 1089-101
9. International HMFCG. Reducing the burden of zoster-associated pain: update. IHMF Management Strategies Workshop. Worthing (England): PPS Europe Ltd, 1995
10. Boon R. Efficacy and safety of famciclovir in the treatment of herpes poster [oral presentation]. The Second International Conference on the Varicella Zoster Virus: 1994 Jul 7-8; Paris
11. Beutner KR, Friedman DJ, Forszpaniak C, et al. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995; 39: 1546-52
12. Dworkin RH, Hartstein G, Rosner HL, et al. A high-risk method for studying psychosocial antecedents of chronic pain: the prospective investigation of herpes zoster. J Abnorm Psychol 1992; 101 (1): 1-20
13. Rose MJ, Klenerman L, Atchison L, et al. An application of the fear avoidance model to three chronic pain problems. Behav Res Ther 1992; 30: 359-65
14. Leijon G, Boivie J, Rosberg M, et al. Sensory abnormalities accompanying herpes zoster and post-herpetic neuralgia. 7th World Congress on Pain; 1993 Aug: Paris. Seattle: IASP Press, 1993
15. Wilson JB. Thirty one years of herpes zoster in a rural practice. BMJ 1986; 293: 1349-52
16. Higa K, Mori M, Hirata K, et al. Severity of skin lesions of herpes zoster at the worst phase rather than age and involved region influences most the duration of acute herpetic pain. Pain. In press
17. Dworkin RH, Cooper EM, Walther RR, et al. Predicting the development of postherpetic neuralgia in acute herpes zoster patients: a diathesis-stress model [abstract/poster]. American Pain Society Annual Meeting. Los Angeles: American Pain Society, 1995
18. McKendrick MW, McGill JI, Bell AM, et al. Oral acyclovir for herpes zoster [letter|. Lancet 1984 Oct 20; 11: 925
19. McKendrick MW. Oral acyclovir in herpes zoster. Scand Infect Dis 1985; 47: 76-9
20. Morton P, Thomson AN. Oral acyclovir in the treatment of herpes zoster in general practice. N Z Med J 1989; 102: 93-5
21. Huff JC, Bean B, Balfour HH, et al. Therapy of herpes zoster with oral acyclovir. Am J Med 1988; 85: 84-9
22. Degreef H, Group FHZCS. Famciclovir for herpes zoster. Int J Antimicrob Agents 1994; 4: 241-6
23. Harding SP, Porter SM. Oral acyclovir in herpes zoster ophthalmicus. Curr Eye Res 1991; 10: 177-82
24. Wood MJ, Kay R, Dworkin RH, et al. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis 1996; 22: 341-7
25. Wood MJ, Ogan PH, McKendrick MW, et al. Efficacy of oral acyclovir treatment of acute herpes zoster. Am J Med 1988; 85: 79-83
26. Johnson RW. The future of predictors, prevention and therapy in postherpetic neuralgia. Neurology 1995; 45 Suppl. 8: S70-2
27. McKendrick MW, Care C, Wood MJ, et al. A retrospective review of herpes zoster and the development of chronic pain [oral presentation]. The Second International Conference on the Varicella Zoster Virus: 1994 Jul 7-8; Paris
28. McKendrick MW, Wood MJ. Acyclovir and post-herpetic neuralgia: two other participating study centres report different results [letter|. BMJ 1995; 310: 1005
29. McGill JI, White JE. Prevention of herpes zoster induced post-herpetic neuralgia and ocular involvement with acyclovir [oral presentation]. The Second International Conference on the Varicella Zoster Virus: 1994 Jul 7-8; Paris
30. McGill JI, White JE. Acyclovir and post-herpetic neuralgia and ocular involvement. BMJ 1994; 309: 1124
31. Lancaster T, Silagy C, Gray S. Primary care management of acute herpes zoster: systematic review of evidence from randomized controlled trials. Br J Gen Pract 1995 Jan; 45: 39-45
32. Johnson RW, Mandal BK. Brief summary of guideline for antiviral use. J Infect 1995; 30: 193-200
33. Juel-Jensen BE, MacCallum FO, Mackenzie AMR, et al. Treatment of zoster with idoxuridine in dimethyl sulphoxide: results of two double-blind controlled trials. BMJ 1970 Dec 26; 4: 776-80
34. Marsh RJ, Cooper M. Double-masked trial of topical acyclovir and steroids in the treatment of herpes zoster ocular inflammation. Br J Ophthalmol 1991; 75: 542-6
35. Neoh C, Harding SP, Saunders D, et al. Comparison of topical and oral acyclovir in early herpes zoster ophthalmicus. Eye 1994; 8: 688-91
36. Bowsher D. Acute herpes zoster and postherpetic neuralgia: effects of acyclovir and outcome of treatment with amitriptyline. Br J Gen Pract 1992; 42: 244-6
37. Bowsher D. The effects of acyclovir therapy for herpes zoster on treatment outcome in postherpetic neuralgia. Eur J Pain 1994; 15: 9-12
38. Bowsher D. Pathophysiology of postherpetic neuralgia: towards a rational treatment. Neurology 1995; 45 Suppl. 8: S56-7
39. Esmann V, Geil JP, Kroon S. Prednisolone does not prevent postherpetic neuralgia. Lancet 1987; 11: 126-9
40. Eaglstein WH, Katz R, Brown JA. The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA 1970; 211: 1681-3
41. Esmann V, Peterslund NA, Ipsen J. Systematic antiviral treatment of herpes zoster. In: Spitzy KH, Karrer K, editors. 13th International Congress of Chemotherapy: 1983 Aug 28-Sep 2; Vienna. Vol. 39, 1983
42. Keczkes K, Basheer AM. Do corticosteroids prevent postherpetic neuralgia? Br J Dermatol 1980; 102: 551-5
43. Wood MJ, Johnson RW, McKendrick MW, et al. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994; 330: 896-900
44. Whitley RJ, Weiss H, Gnann JW, et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomised, placebo-controlled trial. Ann Intern Med 1996; 125: 376-83
45. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965; 150: 971-9
46. Manabe H, Dan K, Higa K. Continuous epidural infusion of local anaesthetics and shorter duration of acute zoster-associated pain. Clin J Pain 1995; 11: 220-8
47. Winnie AP, Hartwell PW. Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of post-herpetic neuralgia: clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Reg Anesth 1993; 18: 277-82
48. Currey TA, Dalsania J. Treatment for herpes zoster ophthalmicus: stellate ganglion block as a treatment for acute pain and prevention of postherpetic neuralgia. Ann Ophthalmol 1991; 23: 188-9
49. Tenicela R, Lovasic D, Eaglstein W. Treatment of herpes zoster with sympathetic blocks. Clin J Pain 1985; 1: 63-7
50. Higa H, Dan K, Manabe H, et al. Factors influencing the duration of treatment of acute herpetic pain with sympathetic nerve block: importance of severity of herpes zoster assessed by the maximum antibody titers to varicella-zoster virus in otherwise healthy patients. Pain 1988; 32: 147-57
51. Ali NM. Does sympathetic ganglionic block prevent postherpetic neuralgia? Literature review. Reg Anesth 1995; 20: 227-33
52. Davies L, Cossins L, Bowsher D, et al. The cost of treatment for post-herpetic neuralgia in the UK. PharmacoEconomics 1994; 6: 142-8
53. British national formulary. 32nd ed. London: British Medical Association/Royal Pharmaceutical Society of Great Britain, 1996 Sep
54. Johnson R, Shukla S, Fletcher P, for the Aciclovir Study Group Qualitative aspects of zoster-associated pain - evaluation of a new approach [abstract/poster]. 1st Scientific Meeting of the European Federation of IASP Chapters. Verona: European Federation of IASP Chapters, 1995
55. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression scale. Acta Psychiatr Scand 1983; 67: 361-70
56. Nathan PW, Wall PD. Treatment of postherpetic neuralgia by prolonged electrical stimulation. BMJ 1974; 3: 645-7
57. Gerson GR, Jones RB, Luscombe DK. Studies of the concomitant use of carbamazepine and clomipramine for the relief of postherpetic neuralgia. Postgrad Med J 1977; 54: 104-9
58. Jones RJ, Silman GM. Trials of ultrasonic therapy for acute herpes zoster. Practitioner 1987; 231: 1336-40
59. Payne C. Ultrasound for post-herpetic neuralgia. Physiotherapy 1984; 70: 96-7
60. Lewith GT, Field F, Machin D. Acupuncture versus placebo in postherpetic pain. Pain 1983; 17: 361-8
61. Dung HC. Acupuncture for the treatment of post-herpetic neuralgia. Am J Acupuncture 1987; 15: 5-14
62. Collins PD. EMLA cream and herpetic neuralgia. Med J Aust 1991; 155: 206-7
63. Stow PJ, Glynn CJ, Minor B. EMLA cream in the treatment of postherpetic neuralgia: efficacy and pharmacokinetic profile. Pain 1989; 39: 301-5
64. Wheeler JG. Emla cream and herpetic neuralgia [letter]. Med J Aust 1991; 154: 781
65. Rowbotham MC, Miller KV, Davies P. Topical lidocaine for post-herpetic neuralgia pain: results of a double-blind, vehicle controlled trial. Neurology 1992; 42 Suppl. 3: 390
66. Rowbotham MC, Davies PS, Verkempinck C, et al. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996; 65: 39-44
67. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991; 41: 1024-8
68. Alexander JI. Post herpetic neuralgia [letter]. Anaesthesia 1985; 40: 1133-4
69. Coniam SW, Hunton J. A study of benzydamine cream in post-herpetic neuralgia. Res Clin Forums 1988; 10: 65-7
70. McQuay HJ, Carroll D, Moxon A, et al. Benzydamine cream for the treatment of post-herpetic neuralgia: minimum duration of treatment periods in a cross-over trial. Pain 1990; 40: 131-5
71. Watson CPN, Tyler KL, Bickers DR, et al. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993; 15: 510-26
72. De Benedittis G, Besana F, Lorenzetti A. A new topical treatment for acute herpetic neuralgia and postherpetic neuralgia: the aspirin/diethyl ether mixture. An open-label study plus a double-blind, controlled clinical trial. Pain 1992; 48: 383-90
73. Haines DR. Topical aspirin in chloroform for post-herpetic neuralgia. J Intractable Pain Soc 1989; 7: 15-6
74. King RB. Concerning the management of pain associated with herpes zoster and of postherpetic neuralgia. Pain 1988; 33: 73-8
75. King RB. Topical aspirin in chloroform and the relief of pain due to herpes zoster and postherpetic neuralgia. Arch Neurol 1993; 88: 556-61
76. De Benedittis G, Lorenzetti A. Topical aspirin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: a double-blind crossover placebo-controlled study. Pain 1996; 65: 45-51
77. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326: 1250-6
78. Max MB. Treatment of post-herpetic neuralgia: antidepressants. Ann Neurol 1994; 35: 50-3
79. Max MB, Schafer SC, Culnane M. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988; 38: 1427-32
80. Watson CP, Evans RJ, Reed K, et al. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982; 32: 671-3
81. Kishore-Kumar R, Max MB, Schafer SC. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 1990; 47: 305-12
82. Watson CPN, Chipman M, Reed K. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized double-blind, crossover trial. Pain 1992; 23: 387-94
83. Watson CPN, Evans RJ. A comparative trial of amitriptyline and zimelidine in post-herpetic neuralgia. Pain 1985; 23: 387-94
84. McQuay H, Carroll D, Jadad AR, et al. Anticonvulsant drugs for the management of pain: a systematic review. BMJ 1995; 311: 1047-52
85. Watson CPN. The medical treatment of postherpetic neuralgia. In: Watson CPN, editor. Herpes zoster and postherpetic neuralgia. Amsterdam: Elsevier, 1993: 205-19
86. Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Arch Neurol 1968; 19: 129-36
87. Raftery H. The management of postherpetic pain using sodium valproate and amitriptyline. Ir Med J 1979; 72: 399-401
88. Hatangdi VS, Boad RA, Richards ED. Postherpetic neuralgia: management with antiepileptic tricyclic drugs. In: Bonica JJ, Albe-Fessard D, editors. Advances in pain research and therapy. Vol. 1. New York: Raven Press, 1976: 583-7
89. Rowbotham MC, Fields HL. Topical lidocaine reduces pain in post-herpetic neuralgia. Pain 1989; 38: 297-301
90. Rowbotham MC. Managing post-herpetic neuralgia with opioids and local anesthetics. Ann Neurol 1994; 35: 46-9
91. Pappagallo M, Campbell JN. Chronic opioid therapy as alternative treatment for post-herpetic neuralgia. Ann Neurol 1994; 35: 54-6
92. Hoffmann V, Coppejans H, Vercauteren M, et al. Successful treatment of postherpetic neuralgia with oral ketamine. Clin J Pain 1994; 10: 240-2
93. Eide PK, Jorum E, Stubhaug A, et al. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 1994; 58: 347-54
94. Bushnell T, Vijay V, Thwaites R, et al. Ketamine is an analgesic in refractory postherpetic neuralgia. J Pain Soc 1996; 12: 93
95. Backonja M, Arndt G, Gombar KA, et al. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 1994; 56: 51-7
96. Kato Y, Homma I, Ichiyanagi K. Postherpetic neuralgia. Pain 1995; 11: 336-7
97. Kristensen JD, Svensson B, Gordh T. The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain 1992; 51: 249-53
98. McQuay HJ, Carroll D, Jadad AR, et al. Dextromethorphan for the treatment of neuropathic pain: a double-blind, randomised controlled crossover trial with integral n-of-1 design. Pain 1994; 59: 127-33
99. Galbraith AW. Treatment of acute herpes zoster with Symmetrel. In: Wink CAS, editor. Report of an International Clinical Symposium: 1971: 45
100. Galbraith AW. Treatment of acute herpes zoster with amantadine hydrochloride (Symmetrel). BMJ 1973; 4: 693-5
101. Parkes D. Amantadine. Adv Drug Res 1975; 8: 11-81
102. Sherlock CH, Corey L. Adenosine monophosphate for the treatment of varicella zoster infections: a large dose of caution. JAMA 1985; 253: 1444-5
103. Sklar SH, Blue WT, Alexander EJ, et al. Herpes zoster: the treatment and prevention of neuralgia with adenosine monophosphate. JAMA 1985; 253: 1427-30
104. Csillik B, Knyihar-Csillik E, Szucs A. Treatment of chronic pain syndromes with iontophoresis of vinca alkaloids to the skin of patients. Neuroscience 1982; 31: 87-90
105. Ikebe H, Miyagawa A, Mizutani A, et al. The effect of iontophoresis with several Ca channel blockers for PHN patients. Masui 1995; 44: 428-33
106. Reiestad F, Kvalheim L, Mcllvaine WB. Pleural analgesia for the treatment of acute severe thoracic herpes zoster. Reg Anesth 1989; 14: 244-6
107. Reiestad F, Mcllvaine WB, Barnes M, et al. Interpleural analgesia in the treatment of severe thoracic postherpetic neuralgia. Reg Anesth 1990; 15: 113-7
108. Thwaites BK, Powell DR. Interpleural block for acute combined cervical and thoracic herpes zoster [letter]. Reg Anesth 1995; 20: 255-6
109. Noordenbos W. Post-herpetic neuralgia. In: Noordenbos W. Pain. Amsterdam: Elsevier, 1959: 4-10
110. Sugar O, Bucy PC. Post-herpetic trigeminal neuralgia. Arch Neurol Psychiatry 1951; 65: 131
111. Oxman MN. Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology 1995; 45: 41-6